REG - Spectra Systems Spectra Systems-SPSC - Appointment of Non-Executive Director

Spectra SystemsAnnouncement

12/09/2022 07:16

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220912:nRSL0182Za&default-theme=true

RNS Number : 0182Z  Spectra Systems Corporation  12 September 2022

Spectra Systems Corporation

("The Company" or "Spectra Systems")

Appointment of Non-Executive Director

Spectra Systems Corporation, a leader in machine-readable high speed banknote
authentication, brand protection technologies and gaming security software is
delighted to announce that it has agreed to appoint Dr. Barbara Paldus (aged
52) as an Independent Non-Executive Director.

Barbara has over 20 years of industry expertise in developing emerging
domestic and international marketplaces, including bio-processing,
personalized medicine, cell therapy, biotech beauty, and analytical process
equipment. She founded two companies whose combined revenue exceeded $250M in
2021. She also has a doctorate in electrical and electronics engineering from
Stanford University.

In 1998 Barbara was a founder of Picarro, a leading provider of
cavity-ring-down instruments (CRDS) and solutions to measure greenhouse gas
(GHG) concentrations, trace gases, and stable isotopes across many scientific
applications, along with the energy, life science, and utilities markets where
she successfully exited in 2006. In 2005 she founded Finess Solutions, a
leader in the development of scalable control automation systems and software
for bioproduction. Its proprietary Smart technology, which consists of
sensors, controllers, and software is designed to optimize the bioproduction
workflow. Finess Solutions was sold to Thermo Fisher in 2017. Barbara was also
an operating partner for Skymoon Ventures from 2005 until  2017, a venture
fund ($100 million invested) focused on early-stage chip, GPS, bioproduction,
optical laser components, and analytical instrumentation.

Barbara is currently the CEO and Founder of Codex Labs, a Global collection of
biotech-based skincare solutions based on disruptive plant-based biotech
ingredients, cGMP manufacturing, industry-leading carbon-footprint minimizing
packaging, and data-driven clinical testing.

Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "I am delighted to welcome
Barbara to Spectra Systems and believe that her extensive entrepreneurial
experience, particularly in technology solutions will be of immense value to
us."

The following information is disclosed pursuant to Schedule Two paragraph (g)
of the AIM Rules for Companies.

Barbara Alice Paldus' directorships and partnerships in the last five years
are as follows:

 

Current Directorships

Codex Beauty Corporation

Codex Beauty Corporation

Sekhmet Ventures LLC

Codex Beauty (UK) Ltd

Codex Labs Europe Ltd

Adva Biotechnology Ltd

Past Directorships

Codex Beauty Service Corporation

Finesse Solutions Inc

Sekhmet Ltd

There is no further information to be disclosed pursuant to paragraph (g) of
Schedule 2 of the AIM Rules.

The information contained within this announcement is deemed to constitute
inside information as stipulated under the retained EU law version of the
Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK
law by virtue of the European Union (Withdrawal) Act 2018. The information is
disclosed in accordance with the Company's obligations under Article 17 of the
UK MAR. Upon the publication of this announcement, this inside information is
now considered to be in the public domain.

Enquiries:

 

 Spectra Systems Corporation                          Tel: +1 (0)401 274 4700

 Dr. Nabil Lawandy, Chief Executive Officer

 WH Ireland Limited (Nominated Adviser and Broker)    Tel: +44 (0)20 7220 1650

 Chris Fielding (Head of Corporate Finance)

 Andrew de Andrade (Executive, Corporate Finance)

 Allenby Capital Limited (Joint Broker)               Tel: +44 (0)20 3328 5665

 Nick Naylor/James Reeve (Corporate Finance)

 Amrit Nahal (Sales and Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABKDBPABKDOCD